About Index Trending news
Lists
Pricing
CytoSorbents

CytoSorbents

CytoSorbents

A public healthcare company in the medical device field that has developed a new hemoperfusion technology for removing toxins from the blood.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO debt
$5,000,000
Employees

Team size

10+
Locations
HQ
Headquarters
$5,000,000 Post-IPO debt
prnewswire

CytoSorbents Receives Additional $5 Million in Non-Dilutive Debt Financing from Bridge Bank